Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ndufv2 as a sex-specific genetic factor influencing mitochondrial functions

Nov. 2, 2021

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

Oct. 28, 2021

mLB-001 GeneRide vector restores hepatocyte function in MMA mice

Oct. 27, 2021

Novel split-intein-based gene therapy strategy to treat Wilson disease

Oct. 27, 2021

Vertex Pharmaceuticals discovers alpha-1-antitrypsin (Z-mutant) polymerization inhibitors

Oct. 27, 2021

VY-NPC101, a potential NPC1-based gene therapy strategy for Niemann-Pick disease type C

Oct. 27, 2021

AAV9-Galns gene therapy corrects mucopolysaccharidosis type IVA pathology in vivo

Oct. 25, 2021

Novel mouse model of spontaneously occurring endometriosis created

Oct. 25, 2021

Targeting GSDMD-mediated pyroptosis as therapeutic strategy for endometriosis

Oct. 22, 2021

Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...